Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DuoTrav BAK Free vs Xalacom in Open-Angle Glaucoma
NCT01779284Phase 4Completed
- Sponsor
- Aristotle University of Thessaloniki
- Start
- Jan 2012
- Primary completion
- Dec 2012
- Modality
- Prodrugs/Conditional Activator Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of travoprost, timolol in Open-angle glaucoma (OAG), pseudoexfoliative glaucoma (PEXG), sponsored by Aristotle University of Thessaloniki. Started Jan 2012; status: completed.
02
Drugs
travoprosttimolol
03
Conditions
Open-angle glaucoma (OAG)pseudoexfoliative glaucoma (PEXG)
Beyond the preview
Go deeper on NCT01779284.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01779284.